Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 45,000
-1,800 (-3.85%)
Oct 10, 2025, 3:30 PM KST
Kolon TissueGene Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -87,801 | -33,799 | -17,224 | -11,136 | -47,370 | -41,788 | Upgrade |
Depreciation & Amortization | 735.31 | 808.55 | 1,412 | 1,665 | 1,551 | 1,642 | Upgrade |
Loss (Gain) From Sale of Assets | 0.24 | -1.02 | 2.17 | - | 14.87 | -0.5 | Upgrade |
Stock-Based Compensation | 99.75 | 79.18 | 67.24 | - | - | 1.33 | Upgrade |
Provision & Write-off of Bad Debts | 8.68 | 3.14 | -29.57 | 241.9 | -107.67 | -89.82 | Upgrade |
Other Operating Activities | 65,881 | 13,103 | -664.36 | -5,653 | 924 | 1,306 | Upgrade |
Change in Accounts Receivable | 31.67 | -57.29 | -120.38 | 58.7 | 343.57 | 336.82 | Upgrade |
Change in Inventory | -9.69 | -34.56 | -47.43 | 89.39 | 124.41 | 61.74 | Upgrade |
Change in Accounts Payable | -124.75 | 71.87 | 150.82 | 12.34 | -151.61 | -218.86 | Upgrade |
Change in Income Taxes | - | - | - | - | -218.54 | -134.56 | Upgrade |
Change in Other Net Operating Assets | -2,297 | -626.28 | -7,655 | -12,054 | 4,870 | 758.25 | Upgrade |
Operating Cash Flow | -23,476 | -20,452 | -24,109 | -26,776 | -40,020 | -38,125 | Upgrade |
Capital Expenditures | -722.97 | -129.26 | -260.58 | -68.52 | -548.04 | -826.74 | Upgrade |
Sale of Property, Plant & Equipment | 5.27 | 1.99 | 1.36 | - | 0.25 | - | Upgrade |
Sale (Purchase) of Intangibles | -104,973 | -77,123 | -45,937 | -24,275 | -5,589 | -12.91 | Upgrade |
Investment in Securities | -13,496 | - | 17,196 | -15,557 | 39,576 | 19,676 | Upgrade |
Other Investing Activities | -35.09 | 5.24 | -39.24 | -156.38 | -89.34 | -128 | Upgrade |
Investing Cash Flow | -119,221 | -77,245 | -29,039 | -40,057 | 33,419 | 18,708 | Upgrade |
Long-Term Debt Issued | - | 23,822 | - | - | - | - | Upgrade |
Total Debt Issued | 79,649 | 23,822 | - | - | - | - | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -5,722 | - | Upgrade |
Long-Term Debt Repaid | - | -1,291 | -1,165 | -1,103 | -3,923 | -6,884 | Upgrade |
Total Debt Repaid | -1,349 | -1,291 | -1,165 | -1,103 | -9,645 | -6,884 | Upgrade |
Net Debt Issued (Repaid) | 78,301 | 22,532 | -1,165 | -1,103 | -9,645 | -6,884 | Upgrade |
Issuance of Common Stock | 44,065 | 46,937 | 39,268 | 37,366 | 34,227 | - | Upgrade |
Other Financing Activities | -0 | -0 | - | 30,646 | - | - | Upgrade |
Financing Cash Flow | 122,366 | 69,468 | 38,102 | 66,909 | 24,582 | -6,884 | Upgrade |
Foreign Exchange Rate Adjustments | 28.6 | -45.52 | 6.64 | -4.43 | 5.09 | - | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | - | 0 | Upgrade |
Net Cash Flow | -20,303 | -28,274 | -15,039 | 72.76 | 17,986 | -26,302 | Upgrade |
Free Cash Flow | -24,199 | -20,581 | -24,370 | -26,844 | -40,568 | -38,952 | Upgrade |
Free Cash Flow Margin | -440.58% | -405.66% | -657.56% | -283.88% | -1013.40% | -1095.44% | Upgrade |
Free Cash Flow Per Share | -302.39 | -267.44 | -339.84 | -404.97 | -662.52 | -637.95 | Upgrade |
Cash Interest Paid | - | - | - | - | 119.8 | 374.11 | Upgrade |
Cash Income Tax Paid | 54.99 | -95.76 | 251.76 | 1,318 | - | - | Upgrade |
Levered Free Cash Flow | -19,390 | -46,515 | -54,983 | -38,159 | -25,649 | -25,937 | Upgrade |
Unlevered Free Cash Flow | -19,339 | -46,459 | -54,804 | -37,927 | -25,358 | -25,415 | Upgrade |
Change in Working Capital | -2,400 | -646.25 | -7,672 | -11,894 | 4,968 | 803.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.